Zoetis CEO Talks Bird Flu Vaccine

Hear from the CEO of a pioneering animal health company as she unveils their groundbreaking avian flu vaccine, now conditionally licensed. Discover strategic insights on managing avian flu through biosecurity and vaccine innovations. The discussion flows into the pharmaceutical landscape, highlighting key product categories and the impact of global dynamics on U.S. operations. This is a fascinating dive into the future of animal health and the vital role of innovation in tackling market challenges.